-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $156

Benzinga·09/04/2026 13:12:23
語音播報
Citigroup analyst Samantha Semenkow initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Buy rating and announces Price Target of $156.